tradingkey.logo
tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.420USD
-0.020-0.82%
終値 12/26, 16:00ET15分遅れの株価
154.17M時価総額
損失額直近12ヶ月PER

Treace Medical Concepts Inc

2.420
-0.020-0.82%

詳細情報 Treace Medical Concepts Inc 企業名

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Incの企業情報

企業コードTMCI
会社名Treace Medical Concepts Inc
上場日Apr 23, 2021
最高経営責任者「CEO」Treace (John T)
従業員数477
証券種類Ordinary Share
決算期末Apr 23
本社所在地100 Palmetto Park Place
都市PONTE VEDRA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号32081
電話番号19043735940
ウェブサイトhttps://www.treace.com/
企業コードTMCI
上場日Apr 23, 2021
最高経営責任者「CEO」Treace (John T)

Treace Medical Concepts Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Tue, Nov 25
更新時刻: Tue, Nov 25
株主統計
種類
株主統計
株主統計
比率
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
他の
56.62%
株主統計
株主統計
比率
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
他の
56.62%
種類
株主統計
比率
Individual Investor
25.43%
Investment Advisor/Hedge Fund
23.25%
Hedge Fund
18.89%
Investment Advisor
16.47%
Research Firm
2.22%
Bank and Trust
0.31%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
他の
13.33%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
908.03K
1.44%
+409.11K
+82.00%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
詳細を見る
iShares U.S. Medical Devices ETF
比率0.04%
Franklin US Small Cap Multifactor Index ETF
比率0.04%
iShares Russell 2000 Growth ETF
比率0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.01%
Schwab U.S. Small-Cap ETF
比率0.01%
Global X Russell 2000 ETF
比率0.01%
ProShares Hedge Replication ETF
比率0.01%
Fidelity Enhanced Small Cap ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
iShares Morningstar Small-Cap ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Treace Medical Concepts Incの上位5名の株主は誰ですか?

Treace Medical Concepts Incの上位5名の株主は以下のとおりです。
Treace (John T.)は11.70M株を保有しており、これは全体の18.53%に相当します。
Armistice Capital LLCは6.26M株を保有しており、これは全体の9.91%に相当します。
William Blair Investment Management, LLCは3.10M株を保有しており、これは全体の4.91%に相当します。
BlackRock Institutional Trust Company, N.A.は3.28M株を保有しており、これは全体の5.20%に相当します。
The Vanguard Group, Inc.は2.73M株を保有しており、これは全体の4.31%に相当します。

Treace Medical Concepts Incの株主タイプ上位3種は何ですか?

Treace Medical Concepts Incの株主タイプ上位3種は、
Treace (John T.)
Armistice Capital LLC
William Blair Investment Management, LLC

Treace Medical Concepts Inc(TMCI)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Treace Medical Concepts Incの株式を保有している機関は338社あり、保有株式の総市場価値は約38.30Mで、全体の60.11%を占めています。2025Q2と比較して、機関の持ち株は-27.77%増加しています。

Treace Medical Concepts Incの最大の収益源は何ですか?

--において、--部門がTreace Medical Concepts Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI